Last quarter (Q3 2024), ImmunoPrecise Antibodies's total revenue was C$6.22M, an increase of 20.31% from the same quarter last year. In Q3, ImmunoPrecise Antibodies's net income was C$-2.94M. See ImmunoPrecise Antibodies’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Apr 23	Apr 22	Apr 21	Apr 20	Apr 19
Total Revenue	C$ 23.68M	C$ 20.66M	C$ 19.36M	C$ 17.91M	C$ 14.06M	C$ 10.93M
Cost of Revenue	C$ 11.39M	C$ 9.10M	C$ 8.38M	C$ 6.37M	C$ 6.02M	C$ 5.63M
Gross Profit	C$ 12.29M	C$ 11.56M	C$ 10.98M	C$ 11.54M	C$ 8.03M	C$ 5.29M
Operating Expense	C$ 28.96M	C$ 40.11M	C$ 27.73M	C$ 15.71M	C$ 11.86M	C$ 11.52M
Operating Income	C$ -16.67M	C$ -28.55M	C$ -16.75M	C$ -4.18M	C$ -3.83M	C$ -6.23M
Net Non Operating Interest Income Expense	C$ 546.00K	C$ 240.00K	C$ 279.00K	C$ -581.00K	C$ -1.39M	C$ -383.50K
Other Income Expense	C$ -296.00K	C$ -332.00K	C$ 160.00K	C$ -1.24M	C$ -82.00K	C$ -1.00M
Pretax Income	C$ -15.77M	C$ -27.75M	C$ -16.00M	C$ -6.00M	C$ -5.29M	C$ -7.61M
Tax Provision	C$ -1.51M	C$ -1.19M	C$ 861.00K	C$ 1.34M	C$ -346.00K	C$ 4.79K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	C$ -14.26M	C$ -26.56M	C$ -16.86M	C$ -7.34M	C$ -4.95M	C$ -7.62M
Basic EPS	C$ -0.55	C$ -1.07	C$ -0.85	C$ -0.45	C$ -0.35	C$ -0.60
Diluted EPS	C$ -0.55	C$ -1.07	C$ -0.85	C$ -0.45	C$ -0.35	C$ -0.60
Basic Average Shares	C$ 100.80M	C$ 24.90M	C$ 19.69M	C$ 16.47M	C$ 13.63M	C$ 12.54M
Diluted Average Shares	C$ 100.80M	C$ 24.90M	C$ 19.69M	C$ 16.47M	C$ 13.63M	C$ 12.54M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	C$ 191.00K	C$ 128.00K	C$ 324.40K
Total Expenses	C$ 30.49M	C$ 49.22M	C$ 36.11M	C$ 22.09M	C$ 17.88M	C$ 17.15M
Net Income From Continuing And Discontinued Operation	C$ -14.26M	C$ -26.56M	C$ -16.86M	C$ -7.34M	C$ -4.95M	C$ -7.62M
Normalized Income	C$ -16.63M	C$ -28.94M	C$ -11.76M	C$ -6.43M	C$ -4.87M	C$ -6.88M
Interest Expense	-	-	-	C$ 863.00K	C$ 1.44M	C$ 413.59K
EBIT	C$ -15.80M	C$ -27.72M	C$ -16.00M	C$ -5.13M	C$ -3.86M	C$ -7.20M
EBITDA	C$ -9.67M	C$ -21.04M	C$ -12.23M	C$ -1.42M	C$ -449.00K	C$ -4.94M

Currency in CAD

ImmunoPrecise Antibodies Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing